Patents by Inventor Stephen Manning
Stephen Manning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240149449Abstract: Disclosed example robotic welding systems include: a robotic manipulator configured to manipulate a welding torch; a first input device attached to the robotic manipulator and configured to receive rotational and translational inputs; a second input device attached to the robotic manipulator and configured to receive a masking input; and a robot control system, comprising: a processor; and a machine readable storage medium comprising machine readable instructions which, when executed by the processor, cause the processor to: in response to activation of the masking input via the second input device, masking at least a portion of the inputs received via the first input device; and in response to inputs to the first input device, move the robotic manipulator according to the inputs and based on whether the inputs are masked.Type: ApplicationFiled: November 7, 2023Publication date: May 9, 2024Inventors: Samantha Noland, David Savage, Stephen Zuccaro, James Manning, Praveen Dandu
-
Patent number: 8272186Abstract: The present invention relates to a vent pipe protection cover for repairing damaged flashing or for any new construction for waterproofing the vent pipe. A two piece construction which allows one device to accommodate roof pitches and various size vent pipes without the need to custom make the device is disclosed.Type: GrantFiled: March 15, 2010Date of Patent: September 25, 2012Inventor: Mark Stephen Manning
-
Publication number: 20110219723Abstract: The present invention relates to a vent pipe protection cover for repairing damaged flashing or for any new construction for waterproofing the vent pipe. A two piece construction which allows one device to accommodate roof pitches and various size vent pipes without the need to custom make the device is disclosed.Type: ApplicationFiled: March 15, 2010Publication date: September 15, 2011Inventor: Mark Stephen Manning
-
Publication number: 20090269783Abstract: Novel B7-like polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length B7-like proteins, the invention further provides isolated B7-like fusion proteins, antigenic peptides, and anti-B7-like antibodies. The invention also provides B7-like nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a B7-like gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.Type: ApplicationFiled: August 20, 2008Publication date: October 29, 2009Inventors: Anthony J. Coyle, Christopher C. Fraser, Stephen Manning
-
Patent number: 7432062Abstract: Novel B7-like polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length B7-like proteins, the invention further provides isolated B7-like fusion proteins, antigenic peptides, and anti-B7-like antibodies. The invention also provides B7-like nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a B7-like gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.Type: GrantFiled: August 20, 2003Date of Patent: October 7, 2008Assignee: Millennium Pharmaceuticals, Inc.Inventors: Anthony J. Coyle, Christopher C. Fraser, Stephen Manning
-
Publication number: 20060260146Abstract: An illuminated ruler including a light transmissive bar having opposed ends. An opaque film bearing printed indicia in the form of ruled markings is affixed to the bottom of the light transmissive bar. A light-emitting diode is embedded within the light transmissive bar for illuminating the ruled markings. A battery is carried atop one end of the bar and is connected to the light-emitting diode for energizing and illuminating the light-emitting diode.Type: ApplicationFiled: May 18, 2005Publication date: November 23, 2006Inventor: Stephen Manning
-
Publication number: 20050202013Abstract: Novel Th2-specific polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length Th2-specific proteins, the invention further provides isolated Th2-specific fusion proteins, antigenic peptides, and anti-Th2-specific antibodies. The invention also provides Th2-specific nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a Th2-specific gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.Type: ApplicationFiled: May 3, 2005Publication date: September 15, 2005Inventors: Anthony Coyle, Stephen Manning, Sophie Lehar, Jose-Carlos Gutierrez-Ramos
-
Publication number: 20040137577Abstract: Novel B7-like polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length B7-like proteins, the invention further provides isolated B7-like fusion proteins, antigenic peptides, and anti-B7-like antibodies. The invention also provides B7-like nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a B7-like gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.Type: ApplicationFiled: August 20, 2003Publication date: July 15, 2004Applicant: Millennium Pharmaceuticals, Inc.Inventors: Anthony J. Coyle, Christopher C. Fraser, Stephen Manning
-
Patent number: 6635750Abstract: B7-like polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length B7-like proteins, the invention further provides isolated B7-like fusion proteins, antigenic peptides, and anti-B7-like antibodies. The invention also provides B7-like nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a B7-like gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.Type: GrantFiled: July 20, 2000Date of Patent: October 21, 2003Assignee: Millennium Pharmaceuticals, Inc.Inventors: Anthony J. Coyle, Christopher C. Fraser, Stephen Manning
-
Patent number: 6630575Abstract: B7-Like polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length B7-like proteins, the invention further provides isolated B7-like fusion proteins, antigenic peptides, and anti-B7-like antibodies. The invention also provides B7-like nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a B7-like gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.Type: GrantFiled: July 20, 2001Date of Patent: October 7, 2003Assignee: Millennium Pharmaceuticals, Inc.Inventors: Anthony J. Coyle, Christopher C. Fraser, Stephen Manning
-
Publication number: 20020164697Abstract: Novel Th2-specific polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length Th2-specific proteins, the invention further provides isolated Th2-specific fusion proteins, antigenic peptides, and anti-Th2-specific antibodies. The invention also provides Th2-specific nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a Th2-specific gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.Type: ApplicationFiled: November 20, 2001Publication date: November 7, 2002Applicant: Millennium Pharmaceuticals, Inc.Inventors: Anthony J. Coyle, Stephen Manning, Sophie Lehar, Jose-Carlos Gutierrez-Ramos
-
Publication number: 20020106730Abstract: Novel B7-like polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length B7-like proteins, the invention further provides isolated B7-like fusion proteins, antigenic peptides, and anti-B7-like antibodies. The invention also provides B7-like nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a B7-like gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.Type: ApplicationFiled: July 20, 2001Publication date: August 8, 2002Applicant: Millennium Pharmaceuticals, Inc.Inventors: Anthony J. Coyle, Christopher C. Fraser, Stephen Manning